Abstract: Post operative nausea and vomiting (PONV) 
Introduction
Postoperative nausea and vomiting (PONV) remains one of the most common complications related to surgery and anaesthesia. Referred to as the "big little problem", its complications range from minor patient discomfort to gastric aspiration. Postoperative nausea and vomiting (PONV) can occur after general, regional or local anaesthesia. [1] An overall estimate of PONV is approximately 20-30 % of all adult surgical patients. [2] Most investigators have reported a significantly higher incidence of nausea and vomiting after surgery in female adults compared to male adults. [2] The incidence of PONV after day care and laparoscopic surgeries varies from 36-82 % during immediate postoperative recovery and can be as high as 73 % in certain gynecological procedures [3] . There are multiple contributing factors that stimulate the vomiting reflex in PONV, yet no single component is typically the causative factor. The anesthesia related factors associated with emesis included premedication, inhalational agents, opioids, postoperative pain, patient mobilization, hemodynamic instability and initiation of oral intake. [4] Many different antiemetic drugs are available for treatment of PONV. Balanced antiemesis, using drug combinations with different mechanisms and site of action is a better and worthwhile approach than single drug therapy. [5, 6] The introduction of 5-hydroxytryptamine (5-HT3) receptor antagonist was a major advancement in the treatment of postoperative nausea and vomiting because of the less adverse effects that were observed than commonly used traditional antiemetics [7] . Ondansetron is selective 5-HT3 receptor antagonist possess property of superior antiemetic prophylaxis and is widely used for treatment of postoperative nausea and vomiting [8, 9] . Granisetron a newer 5-HT3 antagonist has stronger receptor binding and has been found to be more potent and longer acting than ondansetron as antiemetic in chemotherapy and also for preventing postoperative nausea and vomiting following laparoscopic surgeries [9] . The present study was undertaken to comparatively evaluate the efficacy of 5-HT 3 antagonists Ondansetron and Granisetron for the prevention of PONV in female patients undergoing laparoscopic cholecystectomy
II. Patients And Methods
This prospective randomized double blind study included 100 female patients aged 15 -60 years, belonging to ASA I class, undergoing laparoscopic cholecystectomy under general anaesthesia. A proper approval from the local ethics committee and informed consent was taken from the patients included in the study. In the preoperative holding area, patients were randomly allocated into two groups of 50 patients each and received study medications prepared by a single person in identical 5 ml syringe and all study medications were diluted upto 5 ml in 0.9 % saline in order to ensure blinding. Group X patients received 0.1mg/Kg of ondansetron diluted to 5ml in 0.9% saline. In the operating room, after establishing an intravenous line, the study medication was administered one minute prior to induction of anaesthesia. Anaesthesia was induced with 5mg/kg of 2.5 % thiopentone sodium, atracurium 0.5 mg/kg and morphine 100µg/kg followed by maintenance with nitrous oxide 66% in oxygen and supplemented with 0.5 -1% halothane and atracurium 100µg/kg based on neuromuscular monitoring done by train of four stimulation.
After tracheal intubation, a nasogastric tube was placed to promote baseline empting of stomach of air and gastric contents, which was removed at the end of surgery before tracheal extubation. During surgery, patients were positioned in the reverse Trendelenberg position with the right side of the table elevated. The abdomen was insufflated with CO 2 , to an intraabdominal pressure of 10 -14 mm Hg. Intraoperative monitoring included ECG, pulse oximetry, non invasive blood pressure monitoring, which recorded systolic, diastolic and mean arterial blood pressure every 5 minutes. Duration of anaesthesia, surgery and CO 2 insufflation were also recorded in each patient. Paracetamol 15mg/Kg i/v was given towards the end of surgery. At the end of surgery neuromuscular block was reversed with neostigmine and glycopyrrolium.
After surgery patients were observed for a period of 24 hours by the same anaesthetist. Diclofenac sodium 75 mg i/m was used as a rescue analgesic if patient complained of pain and requested for analgesia. The incidence of nausea and vomiting was recorded every 6 hourly for a period of 24 hours. No distinction was made between vomiting and retching (retching event was considered as vomiting event).
Nausea and vomiting was evaluated on a three point scale. 0 = none 1 = nausea 2 = vomiting
Rescue antiemetic medication was given in the form of injection (Ondansetron 0.1 mg/kg body weight) and repeated if the patient experienced severe nausea or if there were more than 3 emetic episodes with in a period of 15 minutes or if patient asked for it.
Pain intensity was assessed using a 10 cm visual analogue (VAS 0 = no pain to 10 =severe pain). Pain intensity was classified into 3 categories for easy statistical analysis. Severe if VAS score >7, moderate if VAS score 3 -7, mild if VAS score < 3. Data collected was statistically evaluated and analyzed. Parametric data was expressed as mean ± SD, thereby the inter group comparisons were made by student's t-test .The test was two sided and referred for p-value for its significance. P-value less than 0.05 (p< 0.05) was taken to be statistically significant. The analysis was performed on SSPS version 11.3, statistical software for social sciences, Chicago, U.S.A for windows.
III. Results
There was no statistical difference between the two groups with regards to age, weight, duration of surgery and anaesthesia, duration of CO2 insufflation (TABLE 1).The variation of VAS score between the two groups at 1 and 2 hours was statistically insignificant (p=0.245 and 0.269 respectively). The variation in VAS score at 3, 4 & 24 hours was again statistically insignificant. No patient experienced severe pain (score > 7) at any stage of time in both groups. (TABLE 2) In Group X (Ondansetron group), a complete response (PONV score 0) was observed in 34 patients (68%) during 0 -6 hours after anaesthesia, whereas during further study intervals, complete response was seen in lesser number of patients, with score 0 in only 24 patients (48 %) at 24 hours post operatively. Similarly during 0 -6 hours of study 11 patients (22%) had nausea (PONV score 1) where as 5 patients (10%) had vomiting (PONV score 2), showing an overall incidence of emetic episode in 16 patients (32%). The incidence of emetic episode increased further during next study intervals and was 56 % at 24 hours post operatively (TABLE 3) In group Y (Granisetron group), during 0 -6 hours after anaesthesia complete antiemetic response (PONV score 0) was observed in 41 patients (82%) which during further study intervals remained more or less same, and at 24 hours postoperatively was seen in 40 patients (80%). The overall incidence of emetic episode in group Y during 0 -6 hours of study was 18 % with nausea (PONV score 1) seen in 7 patients (14%) and vomiting (PONV score 2) only in 2 patient (4%). At 24 hours after the surgery, the incidence of emetic episode was 20 % with only 10 patients experiencing nausea and vomiting (TABLE 4) . During 0 -6 hours after anaesthesia 9 (18%) patients in group Y and 16 (32%) patients in group X reported nausea and vomiting with insignificant variation, whereas at 6 -12 hours after anaesthesia, the variation in the incidence was significant (p=0.045) with 7 (14%) patients in group Y reporting nausea and vomiting as compared to 16 (32%) patients in group X. Similarly the incidence of nausea and vomiting was found to be highly significant between the groups during 12 -18 and 18 -24 hours, with 9 (18%) and 10 (20%) patients in group Y as compared to 25 ( 50%) and 28 (56%) patients respectively in group X reporting nausea and vomiting during each time intervals (TABLE 5 & 6).
In group X 15 patients (30%) asked for rescue anti-emetic where as in group Y only 2 patients (4%) respectively required rescue anti-emetic. Requirement for rescue antiemetic medication in the two groups showed a statistically highly significant difference (p<0.001) (TABLE 7)
IV. Discussion
Post operative nausea and vomiting (PONV) are considered as very unpleasant side effects of anaesthesia, causing distress and dissatisfaction to patients. It is multifactorial and despite advances in antiemetic therapy the incidence is high. The main patient related factors are age, gender, history of motion sickness, previous post operative nausea and vomiting and pregnancy. The management of post operative nausea and vomiting is based primarily on treatment rather than prevention.
The three most common causes of admission following day care surgery are pain bleeding and vomiting [11] . Females are associated with higher incidence of PONV than males [2, 11, 13] and may on average suffer three times more than males [12] . Women are more sensitive to emetic stimuli. The mechanism of post operative nausea and vomiting in them is complicated by prevailing hormone status. [8] After laparoscopic cholecystectomy its incidence has been reported to be as high as 40-70%. Naguib et al [14] demonstrated that the incidence of PONV after laparoscopic surgeries in the placebo group was remarkably high (72%). In our study the factors that would have contributed to nausea and vomiting may be laparoscopic surgery, use of halothane, morphine, nitrous etc.
We conducted study on 100 ASA I patients with demographic data in terms of age, weight, which were similar in the two groups. There was no significant difference in the Ondansetron and Granisetron Groups (p <0.05) in terms of age and weight. Study done by Paxton [15] showed that PONV is more common in young age group and obese patients.
The quest for effective antiemetic drug without the potential for sedation, or extrapyramidal symptoms and other side effects lead to development of 5HT 3 receptor antagonists i.e. Ondansetron, Granisetron, Topisetron, Palmosetron etc. Recently drug combinations with different mechanism and site of action have been used to achieve enhanced anti-emesis against PONV.
Our study shows no statistical significant difference in the baseline values of hemodynamic variables between the two groups, before during or after giving the study drugs. In PACU we recorded the SBP, DBP and HR at regular intervals. No hemodynamic alterations between the results were observed. The study by Dev [16] also showed the same results.
In our study, a complete response (no nausea and vomiting) was observed in 80 % patients in Granisetron group as compared to 48 % in Ondansetron group, the difference was statistically highly significant. A statistically highly significant reduction (p<0.001) in the incidence of PONV was observed in Group Y when compared with Group X after the 12 hours of surgery. Only 4% of patients in Group Y required rescue antiemetic medication as compared to 30% in Group X which was statistically highly significant.
According to Raphael [17] optimal dose of Ondansetron for preventing post operative nausea and vomiting is 4mg and half life is 3 hours. While optimal dose of Granisetron is 2mg and half life is 8-9 hours. So it is concluded that after 6 hours granisetron is more effective than ondansetron for preventing PONV. Present study showed that Granisetron is better than Ondansetron for preventing PONV. Bhattacharya [18] in his study showed same results. Mikawa K et al [20] reported the elimination half life of granisetron is 9 hours which is 2.5 hours longer than ondansetron, so it requires less frequent dosing which is in agreement with our study as shown be the usage of more rescue antiemetics in ondansetron group as compared with the granisetron group. Janknegt [19] studied that if ondansetron is given at induction time, it is ineffective in preventing PONV, so we administered study drug half an hour before end of surgery. This makes the drug to be more effective postoperatively for longer time.
Our results are in congruence with the study of B.B.Kushwaha et al [23] who concluded that the incidence of PONV were maximum in the first 6 hours but granisetron showed higher incidence during 12-18 hours, whereas ondansetron showed higher incidence during the late postoperative period.
Y.Fujii et al [22] reported that the effective dose of oral granisetron for prophylaxis of prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy, the incidence of emesis free period was 60% with granisetron 1mg, 83% with 2mg and 83% with 4mg granisetron dose ( p <0.01) compared with placebo 53%. Preoperatively oral granisetron dose higher than 2mg was effective for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. It is comparable with our study where our efficacy was 80% with granisetron using a dose of 0.04mg/Kg.
Incidence of Headache was 18% in Ondansetron group while it was 11% in Granisetron group showing a statistically significant difference (p< 0.05). According to a study by Mitra [21] , the incidence of headache and constipation is more in the ondansetron than granisetron group which matches with our results. Incidence of constipation and dizziness were not significant on comparison between the 2 groups X &Y.
V. Conclusion
In conclusion prophylactic administration of Granisetron is more effective than Ondansetron when used alone in reducing the incidence of PONV with prolonged effects.
